AlphaYouRB
Insider selling
Robert Barrow sold $722K of Definium Therapeutics, Inc. (DFTX) stock
Robert Barrow, Chief Executive Officer of Definium Therapeutics, Inc. (DFTX), sold 19,023 shares of DFTX stock worth $722K, per an SEC Form 4 filed Sep 5, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Sep 2, 2026, 3 days before it was made public.
DFTX has moved +1.0% since the trade date, from $38.90 to $39.28 (Sep 21, 2026 close).
- Traded
- Sep 2, 2026
- Disclosed
- Sep 5, 2026
- Filing delay
- 3 days
- Price since
- +1.0%
- Role
- Chief Executive Officer
- Source
- SEC Form 4
More DFTX insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.